Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Neuroendocrine Tumors 131Pituitary Neoplasms 72Thyroid Cancer, Papillary 59Pheochromocytoma 55Multiple Endocrine Neoplasia Type 1 31Thyroid Neoplasms 30Paraganglioma 29Adrenal Gland Neoplasms 27Neoplasms 26Pancreatic Neoplasms 21Carcinoid Tumor 20Adrenocortical Carcinoma 19Hyperaldosteronism 17Cushing Syndrome 17Carcinoma, Neuroendocrine 17Gastro-enteropancreatic neuroendocrine tumor 16Acromegaly 15Pituitary Diseases 14Lung Neoplasms 13Stomach Neoplasms 11Prostatic Neoplasms 11Neoplasm Metastasis 11Carcinoma, Hepatocellular 11Breast Neoplasms 11Multiple Endocrine Neoplasia 10Melanoma 10Thyroid Carcinoma, Anaplastic 9Prolactinoma 9Lymphatic Metastasis 9Insulinoma 9

Interventions

Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × ACTH-Secreting Pituitary Adenoma × Endocrine × Clear all
NCT07463625 2026-03-11

PiTFET

Hospices Civils de Lyon

Recruiting
20 enrolled
Endocrine

Pituitary Diseases, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT06701838 2024-12-03

OPTIMAL

Imperial College London

Not yet recruiting
15 enrolled
Endocrine

Cushing Syndrome, Pituitary Neoplasms, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡